Page last updated: 2024-10-26

diphenyleneiodonium and Cardiovascular Diseases

diphenyleneiodonium has been researched along with Cardiovascular Diseases in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Speer, T1
Owala, FO1
Holy, EW1
Zewinger, S1
Frenzel, FL1
Stähli, BE1
Razavi, M1
Triem, S1
Cvija, H1
Rohrer, L1
Seiler, S1
Heine, GH1
Jankowski, V1
Jankowski, J1
Camici, GG1
Akhmedov, A1
Fliser, D1
Lüscher, TF1
Tanner, FC1

Other Studies

1 other study available for diphenyleneiodonium and Cardiovascular Diseases

ArticleYear
Carbamylated low-density lipoprotein induces endothelial dysfunction.
    European heart journal, 2014, Nov-14, Volume: 35, Issue:43

    Topics: Acetylcholine; Analysis of Variance; Animals; Aorta; Cardiovascular Diseases; Endothelium, Vascular;

2014